The goal of the Academic Drug Discovery Consortium (ADDC) is to build a collaborative network among the growing number of university-led drug discovery centers and programs. With this interactive website, we aim to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. It is with the active participation of each ADDC member that this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of our members will enable the ADDC to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs.
The Eskitis Institute is a drug discovery research centre. We search for and develop new drug- and cell-based therapies in the areas of:Cancer,Infectious disease, Neurological diseases andGlobal health
Our research is supported by the unique N...
Merck Serono and Feinstein Institute the research arm of North Shore-Long Island Jewish Health System in New York have entered into a joint collaboration to develop new antibody based therapies to treat Systemic Lupus Erythematosus (SLE). Merck Se...View all
Discovery Chemistry Congress
17 February, 2015
9th Drug Discovery for Neurodegeneration: An Intensive Course of Translating Researh into Drugs
01 March, 2015